Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle

Human Molecular Genetics

Volumn 5, Issue 11, 1996, Pages 1703-1712

  Yang, Yiping ^a   Haecker, Sarah Ehlen ^a   Su, Qin ^a   Wilson, James M ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CAPSID PROTEIN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOMODULATION; INFLAMMATION; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT GENE; REPORTER GENE; SKELETAL MUSCLE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BETA-GALACTOSIDASE; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL;

ADENOVIRIDAE; ANIMALIA; MIRIDAE; MURINAE;

EID: 0029825458     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.11.1703     Document Type: Article

References (28)

1. Morgan, J.E. (1994) Cell and gene therapy in Duchenne muscular dystrophy. Hum. Gene Ther., 5, 165-173.
2. Dhawan, J., Pan, L.C., Pavlath, G.K., Travis, M.A., Lanctot, A.M. and Blau, H.M. (1991) Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science, 254, 1509-1512.
3. Barr, E. and Leiden, J.M. (1991) Systemic delivery of recombinant proteins by genetically modified myoblasts. Science, 254, 1507-1509.
4. Acsadi, G., Jani, A., Huard, J., Blaschuk, K., Massie, B., Holland, P., Lochmuller, H. and Karpati, G. (1994) Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther., 1, 338-340.
5. Quantin, B., Perricaudet, L.D., Tajbakhsh, S. and Mandel, J.-L. (1992) Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl Acad. Sci. USA, 89, 2581-2584.
6. Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Couton, D., Cartaud, J., Briand, P., Kaplan, J.C., Perricaudet, M. and Kahn, A. (1993) Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature, 361, 647-650.
7. Vincent, N., Ragot, T., Gilgenkrantz, H., Couton, D., Chafey, P., Gregoire, A., Briand, P., Kaplan, J.-C., Kahn, A. and Perricaudet, M. (1993) Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet., 5, 130-134.
8. Acsadi, G., Lochmuller, H., Jani, A., Huard, J., Massie, B., Prescott, S., Simoneau, M., Petrof, B.J. and Karpati, G. (1996) Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther., 7, 129-140.
9. Dai, Y., Schwarz, E.M., Gu, D., Zhang, W., Sarvetnick, N. and Verma, I. (1995) Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl Acad. Sci. USA, 92, 1401-1405.
10. Vilquin, J.-T., Guerette, B., Kinoshita, I., Roy, B., Goulet, M., Gravel, C., Roy, R. and Tremblay, J.P. (1995) FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther., 6, 1391-1401.
11. Yang, Y., Ertl, H.C.J. and Wilson, J.M. (1994) MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity, 1, 433-442.
12. Yang, Y., Li, Q., Ertl, H.C.J. and Wilson, J.M. (1995) Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol., 69, 2004-2015.
13. Wilson, J.M. (1995) Gene therapy for cystic fibrosis: challenges and future directions. J. Clin. Invest., 96, 2547-2554.
14. Yang, Y., Nunes, F., Berencsi, K., Gønczøl, E., Engelhardt, J. and Wilson, J. (1994) Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet., 7, 362-369.
15. Yang, Y., Xiang, Z., Ertl, H.C.J. and Wilson, J.M. (1995) Upregulation of class I MHC antigens by interferon-γ is necessary for the T cell-mediated elimination of recombinant adenovirus infected hepatocytes in vivo. Proc. Natl Acad. Sci. USA, 92, 7257-7261.
16. Yang, Y., Trinchieri, G. and Wilson, J.M. (1995) Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med., 1, 890-893.
17. DeMatteo, R.P., Markmann, J.F., Kozarsky, K.F., Barker, C.F. and Raper, S.E. (1996) Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Ther., 3, 4-12.
18. Lochmuller, H., Petrof, B.J., Allen, C., Prescott, S., Massie, B. and Karpati, G. (1995) Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. Biochem. Biophys. Res. Com., 213, 569-574.
19. Tripathy, S.K., Black, H.B., Goldwasser, E. and Leiden, J.M. (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med., 2, 545-550.
20. Yang, Y., Greenough, K. and Wilson, J.M. (1996) Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther., 3, 412-420.
21. Kay, M., Holterman, A., Meuse, L., Gown, A., Ochs, H., Linsley, P. and Wilson, C. (1995) Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genet., 11, 191-197.
22. Durie, F.H., Foy, T.M., Masters, S.R., Laman, J.D. and Noelle, R.J. (1994) The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today, 15, 406-411.
23. Yang, Y., Jooss, K.U., Su, Q., Ertl, H.C.J. and Wilson, J.M. (1996) Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther., 3, 137-144.
24. Yang, Y., Su, Q. and Wilson, J.M. (1996) The role of viral antigens in destructive cellular immune responses to adenoviral vector-transduced cells in mouse lung. J. Virol., 70, 7209-7212.
25. Hughes, S.M. and Blau, H.M. (1992) Muscle fiber pattern is independent of cell lineage in postnatal rodent development. Cell, 68, 659-671.
26. Danko, I., Fritz, J.D., Jiao, S., Hogan, K., Latendresse, J.S. and Wolff, J.A. (1994) Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther., 1, 114-121.
27. Kochanek, S., Clemens, P.R., Mitani, K., Chen, H.-H., Chan, S. and Caskey, C.T. (1996) A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl Acad. Sci. USA, 93, 5731-5736.
28. Kozarsky, K.F., Donahee, M., Jooss, K., Strauss, J.F. and Wilson, J.M. (1996) Effective treatment of familial hypercholesterolemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nature Genet., 13, 54-62.